FDA Revokes Emergency Use Authorization For Hydroxychloroquine In COVID-19

Share
The agency said its own analysis of the EUA, issued in March, and emerging data showed the drug and a related compound, chloroquine, were unlikely to be effective. The Trump administration had aggressively promoted the drug despite a lack of supporting scientific evidence.

Leave a Reply

Your email address will not be published. Required fields are marked *